Literature DB >> 10498913

Strategies for targeting therapeutic gene delivery.

K W Peng1.   

Abstract

A major goal for gene therapy is to obtain targeted vectors that transfer genes efficiently to specific cell types. In theory, this can be achieved by targeting entry of the vector or by building gene expression cassettes that restrict gene expression to certain cell types. This review summarizes recent strategies to alter vector tropism for targeted gene delivery.

Mesh:

Substances:

Year:  1999        PMID: 10498913     DOI: 10.1016/s1357-4310(99)01579-8

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  7 in total

1.  Clinical practice in the new era. A fusion of molecular biology and classical medicine is transforming the way we look at and treat diseases.

Authors:  A G Papavassiliou
Journal:  EMBO Rep       Date:  2001-02       Impact factor: 8.807

Review 2.  Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy.

Authors:  F M Platt; M Jeyakumar; U Andersson; D A Priestman; R A Dwek; T D Butters; T M Cox; R H Lachmann; C Hollak; J M Aerts; S Van Weely; M Hrebícek; C Moyses; I Gow; D Elstein; A Zimran
Journal:  J Inherit Metab Dis       Date:  2001-04       Impact factor: 4.982

Review 3.  Gene therapy in the treatment of intestinal inflammation.

Authors:  Catherine van Montfrans; Anje A te Velde; Sander J H van Deventer; Maria Sol Rodriguez Pena
Journal:  Int J Colorectal Dis       Date:  2003-06-25       Impact factor: 2.571

4.  Adeno-associated virus structural biology as a tool in vector development.

Authors:  Lauren M Drouin; Mavis Agbandje-McKenna
Journal:  Future Virol       Date:  2013-12       Impact factor: 1.831

Review 5.  Toxin-based therapeutic approaches.

Authors:  Assaf Shapira; Itai Benhar
Journal:  Toxins (Basel)       Date:  2010-10-28       Impact factor: 4.546

Review 6.  Gene therapy for carcinoma of the breast: Genetic toxins.

Authors:  G Vassaux; N R Lemoine
Journal:  Breast Cancer Res       Date:  1999-12-17       Impact factor: 6.466

7.  In vivo transcriptional targeting into the retinal vasculature using recombinant baculovirus carrying the human flt-1 promoter.

Authors:  Agustín Luz-Madrigal; Carmen Clapp; Jorge Aranda; Luis Vaca
Journal:  Virol J       Date:  2007-09-18       Impact factor: 4.099

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.